Michael Walsh

Associate Professor

McMaster University

Canada

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

40%

Pharmacotherapy

60%

Hemodialysis

50%

Hemostasis

40%

Inflammatory Disease

30%

Therapeutic Apheresis

30%

Patient-reported Outcome

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Strategies for the management of Atrial Fibrillation in patiEnts receiving HemoDialysis (SAFE-HD)

Open Date: 2018-10-01

Close Date: 2020-09-30

Grant: Close

An Integrated Platform for Innovative Pragmatic Cluster-Randomized Registry Trials in Hemodialysis

Open Date: 2017-01-01

Close Date: 2020-12-31

Grant: Close

Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes

Open Date: 2017-01-01

Close Date: 2021-01-01

Grant: Close

Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes

Open Date: 2017-01-01

Close Date: 2021-01-01

Grant: Close

Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1 (MPAC-CKD-1)

Open Date: 2016-07-01

Close Date: 2020-09-30

Articles12

Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids

Article Link

Year:

2024

Authors' Reply: Proton Pump Inhibitors May Cause a Decline in eGFR by Inhibiting Organic Cation Transporter 2–Dependent Creatinine Secretion

Article Link

Year:

2024

A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis

Article Link

Year:

2024

The Effects of Pantoprazole on Kidney Outcomes

Article Link

Year:

2024

Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS)

Article Link

Year:

2024

How the Routine Use of Patient-Reported Outcome Measures for Hemodialysis Care Influences Patient-Clinician Communication

Article Link

Year:

2022

Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT

Article Link

Year:

2022

Impact of Bioelectrical Impedance–Guided Fluid Management and Vitamin D Supplementation on Left Ventricular Mass in Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial

Article Link

Year:

2022

Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXIRx in Patients With ESRD

Article Link

Year:

2022

The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis

Article Link

Year:

2022

Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Joneset al’by Vandergheynstet al

Article Link

Year:

2020

Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care

Article Link

Year:

2020

Collaborators2

Jesper Nørgaard Bech

Aarhus University

DENMARK

Peter Merkel

Professor

University of Pennsylvania

UNITED STATES

How do I reach out?

Meet Kite AI